Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

How do animal phagocytes process bacterial lipopolysaccharides?

R S Munford1

  • 1Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas 75235-8859.

APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica
|June 1, 1991
PubMed
Summary

Phagocytic cells use enzymes to detoxify harmful bacterial lipopolysaccharide (LPS) while preserving its immune-stimulating properties. This process helps prevent excessive inflammation and promotes immunity against bacterial infections.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

C3-Tat/HIV-regulated intraarticular human interleukin-1 receptor antagonist gene therapy results in efficient inhibition of collagen-induced arthritis superior to cytomegalovirus-regulated expression of the same transgene.

Arthritis and rheumatism·2002
Same author

Endogenous regulation of a therapeutic transgene restores homeostasis in arthritic joints.

The Journal of clinical investigation·2002
Same author

The crucial role of systemic responses in the innate (non-adaptive) host defense.

Journal of endotoxin research·2001
Same author

Plasma constituents regulate LPS binding to, and release from, the monocyte cell surface.

Journal of endotoxin research·2001
Same author

Plasma CD14 decreases monocyte responses to LPS by transferring cell-bound LPS to plasma lipoproteins.

The Journal of clinical investigation·2001
Same author

Statins and the acute-phase response.

The New England journal of medicine·2001

Area of Science:

  • Immunology
  • Microbiology
  • Biochemistry

Background:

  • Phagocytic cells are crucial for innate immunity against bacterial pathogens.
  • Gram-negative bacteria possess lipopolysaccharide (LPS), a potent endotoxin, on their outer membrane.
  • LPS can trigger severe inflammatory responses, contributing to sepsis and other pathologies.

Purpose of the Study:

  • To investigate the enzymatic mechanisms by which phagocytic cells detoxify bacterial lipopolysaccharide (LPS).
  • To determine if LPS detoxification by these enzymes preserves its immunogenic and antigenic properties.
  • To elucidate the implications of this process for antibacterial immunity and inflammatory control.

Main Methods:

  • Enzyme assays to analyze the deacylation and dephosphorylation of the lipid A moiety of LPS.

Related Experiment Videos

  • In vivo studies to assess the degradation resistance of the LPS polysaccharide region.
  • Immunological assays to evaluate the retention of antigenic epitopes and immunogenicity.

    • Main Results:

    • Enzymes in phagocytic cells modify the toxic lipid A component of LPS.
    • The polysaccharide portion of LPS demonstrates resistance to degradation in vivo.
    • Detoxified LPS retains its ability to elicit immune responses and serve as an antigen.

    Conclusions:

    • Phagocytic cell enzymes detoxify LPS by targeting the lipid A moiety.
    • Preservation of LPS immunogenicity and antigenicity is achieved through enzymatic modification and resistance of the polysaccharide region.
    • This dual action of LPS detoxification and immunogenicity preservation may balance inflammatory control and adaptive immunity development.